$VYX

NCR Voyix (VYX) Upgraded to Buy: Here's What You Should Know

NCR Voyix (VYX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Original reporting
Zacks Commentary · Zacks Equity Research
Published Aug 22, 2025, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 23, 2025, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
NCR Voyix (VYX) Upgraded to Buy: Here's What You Should Know — source image
Decision brief

The 30-second read

$VYXBullishHigh
01

Why it matters

The upgrade acts as a near-term bullish catalyst, potentially prompting a price re-rating if the earnings outlook proves durable. The market reaction will depend on subsequent earnings results and macro conditions.

02

Market read

Positive near-term catalyst with potential for modest upside in the short run; longer-term outcome depends on earnings execution and broader market conditions.

03

What to watch

Execution risk, competitive dynamics, potential dilution, and macro headwinds may cap upside; lack of price data and volume context increases uncertainty.

Timing: short-term to 2-4 weeks

Background

NCR Voyix (VYX) received a Buy upgrade from Zacks, citing improved earnings prospects and favorable sentiment. Article date converted: 2025-08-22.

Company-level read

Ticker impact

$VYXBullishMedium confidence
Context

Upgrade to Buy by Zacks; earnings optimism; potential re-rating.

Expected impact

Possible 1-6% price rise over the next 1-3 weeks, depending on market conditions and earnings execution; longer-term upside tied to quarterly revisions.

Evidence & confidence

The upgrade to Buy and positive earnings expectations provide a favorable catalyst. However, the actual price move depends on broader market sentiment, sector dynamics, and NCR Voyix's upcoming earnings trajectory. No price targets are available in the article, and real-time liquidity can influence execution.

$VYXBullishMedium confidence
Context

Upgrade catalyst; potential for short-term momentum; limited information on current price and liquidity in the article.

Expected impact

Upside possible if resistance is broken with above-average volume; risk of consolidation if broader market weakness appears.

Evidence & confidence

Catalyst-driven upside is plausible, but technical breakout is not confirmed without price data and volume context. The absence of current price and liquidity details introduces uncertainty.

$VYXBullishLow confidence
Context

Market attention from earnings-driven news; potential spillovers to related fintech/tech equipment peers.

Expected impact

Moderate indirect impact, contingent on broader market participation in the sector.

Evidence & confidence

Direct impact hinges on VYX's earnings actualization and sector-wide momentum; spillover effects are plausible but uncertain without corroborating data.

Market effects

Potential spillover to related fintech/payments technology and mid-cap tech suppliers; positive sentiment for growth-oriented tech names within the sector.

Limited; primarily U.S.-listed equities; possible minor ripple effects in regional tech-heavy indices.

Moderate; may influence sentiment in global tech hardware/payments ecosystems if NCR Voyix has international exposure.

Counterpoint

The upgrade could be anticipated by some investors; if earnings revisions do not materialize, the stock may revert to prior levels or underperform broader markets.

Key entities

  • NCR Voyix

    Ticker VYX; NCR Voyix product line-related business described in the article.

  • Zacks Equity Research

    Source of the upgrade to Buy and associated optimism about earnings prospects.

Related articles

$VYXMed

NCR Voyix Q2 Earnings Call Highlights

NCR Voyix (NYSE:VYX) reported Q2 progress on enterprise platform transformations, including a remote Voyix POS installation for a large European grocery retailer completed in about half the usual time. Retail signed 40+ customers; retail revenue fell 20% to $365M due to hardware transition, but adjusted EBITDA rose 20% to $97M. Restaurant revenue fell 23% to $158M. Non-GAAP EPS was $0.17. Full-year 2026 outlook maintained: revenue $2.188B-$2.303B, adj EBITDA $432M-$447M, EPS $0.89-$0.92.

$VYXMedAI 8/10

NCR Voyix: Q2 Earnings Snapshot

NCR Voyix (VYX) reported Q2 earnings of $2 million and a net loss of 1 cent per share. Adjusted earnings were 17 cents per share, and revenue was $523 million. The company expects full-year earnings of 89 to 92 cents per share and revenue of $2.19 billion to $2.3 billion.

$VYXMed

NCR Voyix Corp (VYX): Completion of Acquisition or Disposition of Assets

NCR Voyix Corp (VYX) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-99.1 2 exhibit991-q22026earningsr.htm EX-99.1 Document NEWS RELEASE NCR Voyix Reports Second Quarter 2026 Results ATLANTA, August 5, 2026 - NCR Voyix Corporation (NYSE: VYX) (“NCR Voyix” or the “Company”), a platform-powered leader in unified commerce for shopping and dining,

$AAPLMed

Apple Tests Chinese Memory Chips As Supply Crunch Pushes PC Giants Toward CXMT

The Wall Street Journal reported Apple is testing memory chips from China’s CXMT across iPhones and MacBooks and has held early talks to supply components for some China-sold devices. Apple is seeking White House approval amid “unsustainable” pricing from SK Hynix, Samsung, Micron and SanDisk. US rules limit customization, but off-the-shelf purchases may be allowed.

$MDTMed

Jury Orders Medtronic to Pay $88 Million After Finding Surgeons Were Not Adequately Warned About a Hernia Mesh

A federal jury ordered Medtronic’s Covidien unit to pay $88 million to Larry and Tammy Patterson after finding surgeons were not adequately warned about risks of Covidien’s Symbotex hernia mesh. The Aug. 4 verdict followed a three-week trial in Massachusetts. Jurors awarded $77 million to Larry and $11 million for loss of consortium, with no punitive damages.

$LMTMedAI 8/10

What is Patriot missile system, why its supplies are down

The article explains the U.S.-made Patriot mobile air defense system and why interceptor missile supplies are down. It cites Raytheon and Lockheed for system details and notes CSIS estimates about 65% of U.S. interceptors were expended Feb to July, leaving under 850. It says the U.S. approved 5,250 interceptors for Gulf states and awarded Lockheed a contract up to $58.6B.